Castle Biosciences Inc.
-
Ticker
CSTL
-
Industry
Diagnostic Substances More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Friendswood, Texas
Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq; www.SkinMelanoma.com), cutaneous squamous
…More cell carcinoma (DecisionDx®-SCC, www.mySCCskincancer.com) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq; www.MyUvealMelanoma.com). Castle also has products in development for other underserved cancers, the most advanced of which is focused on patients who have a difficult-to-diagnose pigmented lesion. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona.
REPORT RATINGS
4.8 / 5.0 (55)
Castle Biosciences Inc. reports have an aggregate usefulness score of 4.8 based on 55 reviews.
Castle Biosciences Inc.
Most Recent Responsibility Report
MOST RECENT
2022 Environmental, Social, and Governance Highlights
Report Locked. Castle Biosciences Inc. has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Castle Biosciences Inc. Sustainability Report, Castle Biosciences Inc. Corporate Social Responsibility Report, Castle Biosciences Inc. CSR Report, Castle Biosciences Inc. Corporate Responsibility, Castle Biosciences Inc. CR Report, Castle Biosciences Inc. Citizenship Report, Castle Biosciences Inc. ESG Report, and Castle Biosciences Inc. Environmental Report online.